GATA-targeted compounds modulate cardiac subtype cell differentiation in dual reporter stem cell line
Abstract Background Pharmacological modulation of cell fate decisions and developmental gene regulatory networks holds promise for the treatment of heart failure. Compounds that target tissue-specific transcription factors could overcome non-specific effects of small molecules and lead to the regene...
Main Authors: | , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2021-03-01
|
Series: | Stem Cell Research & Therapy |
Subjects: | |
Online Access: | https://doi.org/10.1186/s13287-021-02259-z |
id |
doaj-614c3e9ddc044f04a27581297b6207ab |
---|---|
record_format |
Article |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Mika J. Välimäki Robert S. Leigh Sini M. Kinnunen Alexander R. March Ana Hernández de Sande Matias Kinnunen Markku Varjosalo Merja Heinäniemi Bogac L. Kaynak Heikki Ruskoaho |
spellingShingle |
Mika J. Välimäki Robert S. Leigh Sini M. Kinnunen Alexander R. March Ana Hernández de Sande Matias Kinnunen Markku Varjosalo Merja Heinäniemi Bogac L. Kaynak Heikki Ruskoaho GATA-targeted compounds modulate cardiac subtype cell differentiation in dual reporter stem cell line Stem Cell Research & Therapy Stem cells Cardiomyocyte subtype Atrial cardiomyocyte Ventricular cardiomyocyte Heart regeneration GATA4 |
author_facet |
Mika J. Välimäki Robert S. Leigh Sini M. Kinnunen Alexander R. March Ana Hernández de Sande Matias Kinnunen Markku Varjosalo Merja Heinäniemi Bogac L. Kaynak Heikki Ruskoaho |
author_sort |
Mika J. Välimäki |
title |
GATA-targeted compounds modulate cardiac subtype cell differentiation in dual reporter stem cell line |
title_short |
GATA-targeted compounds modulate cardiac subtype cell differentiation in dual reporter stem cell line |
title_full |
GATA-targeted compounds modulate cardiac subtype cell differentiation in dual reporter stem cell line |
title_fullStr |
GATA-targeted compounds modulate cardiac subtype cell differentiation in dual reporter stem cell line |
title_full_unstemmed |
GATA-targeted compounds modulate cardiac subtype cell differentiation in dual reporter stem cell line |
title_sort |
gata-targeted compounds modulate cardiac subtype cell differentiation in dual reporter stem cell line |
publisher |
BMC |
series |
Stem Cell Research & Therapy |
issn |
1757-6512 |
publishDate |
2021-03-01 |
description |
Abstract Background Pharmacological modulation of cell fate decisions and developmental gene regulatory networks holds promise for the treatment of heart failure. Compounds that target tissue-specific transcription factors could overcome non-specific effects of small molecules and lead to the regeneration of heart muscle following myocardial infarction. Due to cellular heterogeneity in the heart, the activation of gene programs representing specific atrial and ventricular cardiomyocyte subtypes would be highly desirable. Chemical compounds that modulate atrial and ventricular cell fate could be used to improve subtype-specific differentiation of endogenous or exogenously delivered progenitor cells in order to promote cardiac regeneration. Methods Transcription factor GATA4-targeted compounds that have previously shown in vivo efficacy in cardiac injury models were tested for stage-specific activation of atrial and ventricular reporter genes in differentiating pluripotent stem cells using a dual reporter assay. Chemically induced gene expression changes were characterized by qRT-PCR, global run-on sequencing (GRO-seq) and immunoblotting, and the network of cooperative proteins of GATA4 and NKX2-5 were further explored by the examination of the GATA4 and NKX2-5 interactome by BioID. Reporter gene assays were conducted to examine combinatorial effects of GATA-targeted compounds and bromodomain and extraterminal domain (BET) inhibition on chamber-specific gene expression. Results GATA4-targeted compounds 3i-1000 and 3i-1103 were identified as differential modulators of atrial and ventricular gene expression. More detailed structure-function analysis revealed a distinct subclass of GATA4/NKX2-5 inhibitory compounds with an acetyl lysine-like domain that contributed to ventricular cells (%Myl2-eGFP+). Additionally, BioID analysis indicated broad interaction between GATA4 and BET family of proteins, such as BRD4. This indicated the involvement of epigenetic modulators in the regulation of GATA-dependent transcription. In this line, reporter gene assays with combinatorial treatment of 3i-1000 and the BET bromodomain inhibitor (+)-JQ1 demonstrated the cooperative role of GATA4 and BRD4 in the modulation of chamber-specific cardiac gene expression. Conclusions Collectively, these results indicate the potential for therapeutic alteration of cell fate decisions and pathological gene regulatory networks by GATA4-targeted compounds modulating chamber-specific transcriptional programs in multipotent cardiac progenitor cells and cardiomyocytes. The compound scaffolds described within this study could be used to develop regenerative strategies for myocardial regeneration. |
topic |
Stem cells Cardiomyocyte subtype Atrial cardiomyocyte Ventricular cardiomyocyte Heart regeneration GATA4 |
url |
https://doi.org/10.1186/s13287-021-02259-z |
work_keys_str_mv |
AT mikajvalimaki gatatargetedcompoundsmodulatecardiacsubtypecelldifferentiationindualreporterstemcellline AT robertsleigh gatatargetedcompoundsmodulatecardiacsubtypecelldifferentiationindualreporterstemcellline AT sinimkinnunen gatatargetedcompoundsmodulatecardiacsubtypecelldifferentiationindualreporterstemcellline AT alexanderrmarch gatatargetedcompoundsmodulatecardiacsubtypecelldifferentiationindualreporterstemcellline AT anahernandezdesande gatatargetedcompoundsmodulatecardiacsubtypecelldifferentiationindualreporterstemcellline AT matiaskinnunen gatatargetedcompoundsmodulatecardiacsubtypecelldifferentiationindualreporterstemcellline AT markkuvarjosalo gatatargetedcompoundsmodulatecardiacsubtypecelldifferentiationindualreporterstemcellline AT merjaheinaniemi gatatargetedcompoundsmodulatecardiacsubtypecelldifferentiationindualreporterstemcellline AT bogaclkaynak gatatargetedcompoundsmodulatecardiacsubtypecelldifferentiationindualreporterstemcellline AT heikkiruskoaho gatatargetedcompoundsmodulatecardiacsubtypecelldifferentiationindualreporterstemcellline |
_version_ |
1724210863196340224 |
spelling |
doaj-614c3e9ddc044f04a27581297b6207ab2021-03-21T12:10:22ZengBMCStem Cell Research & Therapy1757-65122021-03-0112111810.1186/s13287-021-02259-zGATA-targeted compounds modulate cardiac subtype cell differentiation in dual reporter stem cell lineMika J. Välimäki0Robert S. Leigh1Sini M. Kinnunen2Alexander R. March3Ana Hernández de Sande4Matias Kinnunen5Markku Varjosalo6Merja Heinäniemi7Bogac L. Kaynak8Heikki Ruskoaho9Drug Research Program, Division of Pharmacology and Pharmacotherapy, Faculty of Pharmacy, University of HelsinkiDrug Research Program, Division of Pharmacology and Pharmacotherapy, Faculty of Pharmacy, University of HelsinkiDrug Research Program, Division of Pharmacology and Pharmacotherapy, Faculty of Pharmacy, University of HelsinkiDrug Research Program, Division of Pharmacology and Pharmacotherapy, Faculty of Pharmacy, University of HelsinkiInstitute of Biomedicine, School of Medicine, University of Eastern FinlandInstitute of Biotechnology, University of HelsinkiInstitute of Biotechnology, University of HelsinkiInstitute of Biomedicine, School of Medicine, University of Eastern FinlandDrug Research Program, Division of Pharmacology and Pharmacotherapy, Faculty of Pharmacy, University of HelsinkiDrug Research Program, Division of Pharmacology and Pharmacotherapy, Faculty of Pharmacy, University of HelsinkiAbstract Background Pharmacological modulation of cell fate decisions and developmental gene regulatory networks holds promise for the treatment of heart failure. Compounds that target tissue-specific transcription factors could overcome non-specific effects of small molecules and lead to the regeneration of heart muscle following myocardial infarction. Due to cellular heterogeneity in the heart, the activation of gene programs representing specific atrial and ventricular cardiomyocyte subtypes would be highly desirable. Chemical compounds that modulate atrial and ventricular cell fate could be used to improve subtype-specific differentiation of endogenous or exogenously delivered progenitor cells in order to promote cardiac regeneration. Methods Transcription factor GATA4-targeted compounds that have previously shown in vivo efficacy in cardiac injury models were tested for stage-specific activation of atrial and ventricular reporter genes in differentiating pluripotent stem cells using a dual reporter assay. Chemically induced gene expression changes were characterized by qRT-PCR, global run-on sequencing (GRO-seq) and immunoblotting, and the network of cooperative proteins of GATA4 and NKX2-5 were further explored by the examination of the GATA4 and NKX2-5 interactome by BioID. Reporter gene assays were conducted to examine combinatorial effects of GATA-targeted compounds and bromodomain and extraterminal domain (BET) inhibition on chamber-specific gene expression. Results GATA4-targeted compounds 3i-1000 and 3i-1103 were identified as differential modulators of atrial and ventricular gene expression. More detailed structure-function analysis revealed a distinct subclass of GATA4/NKX2-5 inhibitory compounds with an acetyl lysine-like domain that contributed to ventricular cells (%Myl2-eGFP+). Additionally, BioID analysis indicated broad interaction between GATA4 and BET family of proteins, such as BRD4. This indicated the involvement of epigenetic modulators in the regulation of GATA-dependent transcription. In this line, reporter gene assays with combinatorial treatment of 3i-1000 and the BET bromodomain inhibitor (+)-JQ1 demonstrated the cooperative role of GATA4 and BRD4 in the modulation of chamber-specific cardiac gene expression. Conclusions Collectively, these results indicate the potential for therapeutic alteration of cell fate decisions and pathological gene regulatory networks by GATA4-targeted compounds modulating chamber-specific transcriptional programs in multipotent cardiac progenitor cells and cardiomyocytes. The compound scaffolds described within this study could be used to develop regenerative strategies for myocardial regeneration.https://doi.org/10.1186/s13287-021-02259-zStem cellsCardiomyocyte subtypeAtrial cardiomyocyteVentricular cardiomyocyteHeart regenerationGATA4 |